SAFC Biosciences converts Lenexa media milling facility to animal component free
SAFC Biosciences, a provider of cell culture materials and services for the biopharmaceutical industry and a division of Sigma-Aldrich Group, has completed the conversion of its dry powder cell culture media continuous milling production site in Lenexa, Kansas to animal component free (ACF) status. This is the first of several similar conversions planned by SAFC Biosciences to support growing customer requirements for ACF manufacturing.
‘The comprehensive conversion of this facility to ACF status is driven by market requirements that are influenced by regulatory guidance for reducing animal component risk, and by an expanding focus on 'second generation' biologics-based drugs that require ACF production platforms,’ said Bruce Lehr, marketing director at SAFC Biosciences. During the conversion an extensive cleaning conversion protocol was completed and systems and procedures were reviewed and modified appropriately.
Conversion of additional facilities to ACF status is scheduled for completion within the next 12 months in Europe and the US.